RSCM
Rock Springs Capital Management’s Design Therapeutics DSGN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-460,391
| Closed | -$1.09M | – | 107 |
|
2023
Q3 | $1.09M | Hold |
460,391
| – | – | 0.03% | 108 |
|
2023
Q2 | $2.9M | Hold |
460,391
| – | – | 0.07% | 99 |
|
2023
Q1 | $2.66M | Hold |
460,391
| – | – | 0.06% | 101 |
|
2022
Q4 | $4.72M | Hold |
460,391
| – | – | 0.11% | 89 |
|
2022
Q3 | $7.7M | Hold |
460,391
| – | – | 0.2% | 88 |
|
2022
Q2 | $6.45M | Buy |
460,391
+114,794
| +33% | +$1.61M | 0.19% | 91 |
|
2022
Q1 | $5.58M | Buy |
345,597
+10,350
| +3% | +$167K | 0.14% | 100 |
|
2021
Q4 | $7.18M | Buy |
335,247
+1,197
| +0.4% | +$25.6K | 0.17% | 107 |
|
2021
Q3 | $4.91M | Buy |
334,050
+2,000
| +0.6% | +$29.4K | 0.1% | 127 |
|
2021
Q2 | $6.6M | Buy |
332,050
+4,800
| +1% | +$95.5K | 0.13% | 129 |
|
2021
Q1 | $9.79M | Buy |
+327,250
| New | +$9.79M | 0.21% | 118 |
|